Hep G2 cells were incubated under conditions known to influence the HMG-CoA (3-hydroxy-3-methylglutaryl-CoA) reductase activity, e.g. in the presence of compactin (a competitive inhibitor of HMGCoA reductase itself) and U18666A (a squalene-2,3-epoxide cyclase inhibitor). We studied the effects of these conditions both on the HMG-CoA reductase activity and on the reductase mRNA content. In the presence of compactin the mRNA content increased, but less than the enzyme activity, as determined after removal of the inhibitor. The increase in mRNA could be prevented by addition of mevalonate or by a combination of low-density lipoprotein (LDL) plus a low concentration of mevalonate. LDL alone prevented the compactin-induced increases in mRNA and activity only partially. The effect of Ul 8666A on reductase mRNA content and activity was biphasic, i.e. a slight decrease at low (0.3-0.5 /LM) concentrations, with a concomitant formation of polar sterols [Boogaard, Griffioen & Cohen (1987) Biochem. J. 241, [345][346][347][348][349][350][351], and an increase at high (20-30 ,tM) concentrations, with complete blockage of sterol formation. At these high concentrations of Ul 8666A, additional compactin (2 /lM) increased the reductase activity, but not the mRNA content. We conclude that non-sterol metabolites of mevalonate regulate exclusively at the enzyme level, whereas sterol metabolites regulate at the reductase mRNA level. In the latter group of regulators we distinguish mevalonate metabolites which can, and metabolites which cannot, be replaced by exogenous LDL.
INTRODUCTION
It has been shown that the human hepatoma cell line Hep G2 is a suitable model for the study of regulation of cholesterol synthesis in the human hepatocyte (Cohen et al., 1984 (Cohen et al., , 1985 Boogaard et al., 1987; Erickson & Fielding, 1987) . Also in Hep G2 cells HMG-CoA reductase (EC 1.1.1.34), the rate-limiting enzyme in cholesterol biosynthesis, is regulated by endogenous formed metabolites of mevalonate (Cohen et al., 1984) . By blocking the sterol synthesis with the squalene-2,3-epoxide cyclase (EC 5.4.99 .7) inhibitor U18666A {3,8-[2-(diethylamino) ethoxy]androst-5-en-1 7-one} (Sexton et al., 1983) , we were able to show that the sterol components of these metabolites, which seem to be polar sterols, influenced the reductase activity and that additionally non-sterol mevalonate-derived suppressors play a role in the regulation of the enzyme (Boogaard et al., 1987) . The existence of at least two different classes of mevalonate-derived effectors followed also from experiments in which low-density lipoprotein (LDL) could only partially prevent the rise in reductase activity induced by incubation with compactin, a competitive inhibitor of the reductase itself (Endo et al., 1976) . Additionally, mevalonate had to be added to the cells for complete abolition of the compactin effect (Cohen et al., 1985) . However, from these experiments it was not clear whether the additional mevalonate-derived suppressors, which could not be replaced by LDL, belong to the nonsterol class, or whether a sterol component is also involved.
To discriminate better between the apparent distinct regulators of the reductase activity derived from mevalonate, and to gain more insight into the levels on which these regulators act, we compared the changes in enzyme activity with the effects on HMG-CoA reductase mRNA content in Hep G2 cells, after incubations under different conditions. Evidence is provided that non-sterol mevalonate-derived suppressors act at the enzyme level, whereas the endogenous reductase mRNA concentration is regulated by sterol(s), which can be replaced by exogenous LDL and by another sterol class, for which LDL cannot substitute. (Chen, 1967) and loaded with palmitate (Fluka A.G.;1.05 g/ml) was isolated from freshly collected pooled blood by density-gradient ultracentrifugation (Redgrave et al., 1975) . Restriction enzymes HindII and PstI were purchased from Promega and Boehringer Mannheim respectively. Escherichia coli polymerase I was from Pharmacia. All other chemicals were of analytical grade. Human hepatoma cell line Hep G2
MATERIALS AND METHODS
The cells were cultured in 10 cm2 multiwell dishes in DMEM, supplemented with 10 (w/v) foetal-calf serum (Havekes et al., 1983) . At 18 h before harvest, the medium was replaced with DMEM, supplemented with 1 % (w/v) palmitate-loaded albumin and the different constituents as indicated in the Results section. In incubations with U18666A the concentration of the solvent (ethanol) in the medium was 0.150%, which has no significant effect on the reductase activity. HMG-CoA reductase assay HMG-CoA reductase activity was determined in the Hep G2 cell homogenate as described previously (Cohen et al., 1984 ; the [14C]HMG-CoA concentration was 0.5 mM). Values were obtained from duplicate determinations in two homogenates of identically treated cells. The average value for the individual homogenates agreed within 10%. Protein concentrations were determined in the cell homogenate by the method of Lowry et al. (1951) . cDNA probes
The plasmid pHRed-102 containing human HMGCoA reductase cDNA (Luskey & Stevens, 1985) (1982) . Both fragments were labelled by nick-translation (Maniatis et al., 1982) and were shown to hybridize specifically with Hep G2 HMG-CoA reductase and albumin mRNA, respectively, in a Northen-blot analysis (cf. Cohen et al., 1987) . Isolation of RNA from Hep G2 cells After being washed at 37°C three times with phosphate-buffered saline (0.15 M-NaCl/10 mmNa2HPO4/1.5 mM-KH2PO4, pH 7.4), the cells were lysed by gently shaking at 37 IC for 10 min in 0.3 ml (per well) of a buffer containing 50 mM-Tris/HCl, pH 7.5, 0.1 MNaCl, 7.5 mM-EDTA, 1% (w/v) SDS and 150 gg of proteinase K/ml (a minor modification of the procedure of Lizardi & Engelberg, 1979 (BA 85; Schleicher & Schuill) by the procedure described by Van Zonneveld et al. (1986) . For hybridization with the reductase probe, a series of six dots per RNA sample containing between 1.8 and 14 ,g of RNA was loaded. For hybridization with the albumin probe, these series contained between 0.55 and 4.15 ,g of RNA/dot. Prehybridization was performed for at least 6 h at 42°C in 4 x SSC /1 % SDS / 5 x Denhardt's solution / 50 % (v/v) formamide containing denatured salmon sperm DNA (0.1 mg/ml) (Maniatis et al., 1982) . Hybridization took place for 16-20 h at 42°C in the same solution (10 ml) after addition of 0.1,ug of the nick-translated heat-denatured probe. The average specific radioactivity of the HMG-CoA reductase cDNA fragment was 2 x 108 c.p.m./,ug of DNA, and that of the albumin cDNA fragment was 108 c.p.m./,ug of DNA. After hybridization, the blots were washed twice with 2 x SSC (5 min at 20°C), 2 x SSC/0.1 % SDS (30 min at 65°C), 0.1 x SSC/0.1 % SDS (30 min at 65°C) and 0.1 x SSC (at 20°C) successively. The RNA dots hybridized with the albumin cDNA probe were cut out and counted for radioactivity in 4 ml of dioxan scintillator (200-3000 c.p.m./dot). Because the radioactivity bound to the dot-blots hybridized with the reductase cDNA probe was too low for direct counting, these blots were exposed to Hyperfilm MP (Amersham) for 8 h-l week together with an intensifying screen (Kodak) at -80°C, and the autoradiograms were scanned with a Shimadzu CS-910 chromatogram scanner. For each sample the amount of probe hybridized per ,ug of RNA was calculated as the regression coefficient of the linear part of the hybridization curve. In general, all six dots per sample were within this linear part. The albumin-mRNA values were used as an internal mRNA recovery standard; the values for the HMG-CoA reductase mRNA contents are expressed as HMG-CoA-reductase-probe-derived blackening (arbitrary) Fig. 1 . In none of the experiments described in this paper did the quantity of hybridizable albumin mRNA change significantly, so we considered the quantity of this mRNA to be constant Fig. 1 yielded the values as shown in Fig. 2 This is supported by the observation that simultaneously added mevalonate was able to abolish the compactininduced increase (Fig. 2b) . derived from mevalonate were involved in the feedback regulation of the reductase (Boogaard et al., 1987) . The effect of U18666A on HMG-CoA reductase mRNA contents is depicted in Fig. 3 . A slight decrease occurred (Boogaard et al., 1987) . The simultaneous appearance of polar sterols at the low U 18666A concentrations (Boogaard et al., 1987) seems to suggest that these compounds are involved in the decrease in reductase mRNA. The elevation of the mRNA content at high Ul 8666A concentration is thought to be the result of total blockage of sterol formation, indicating that sterols are effective as suppressors at the mRNA level.
The existence of a non-sterol suppressor was shown by determining the reductase activity in cells which had been totally blocked in sterologenesis by U1 8666A and incubated additionally with compactin (2 ftM) and/or mevalonate (3 mM). Under such conditions compactin was still able to induce the reductase activity (2.5 times the activity obtained after incubation with Ul 8666A alone), which could be prevented by mevalonate (Boogaard et al., 1987) . In identically performed experiments the effect on the mRNA content was studied; the results are shown in Fig. 4 . As discussed above, an U18666A-induced increase in mRNA was observed (cf. bars a and c); however, additional compactin in the incubation medium did not lead to a further increase in the quantity of reductase mRNA (cf. bars c and d). The combined effects of U18666A/compactin and mevalonate resulted in the same values (bar e). The control values obtained from incubations with 3 mM-mevalonate (barf) and with compactin plus mevalonate (bar g) agreed with the results discussed above (cf. Fig. 2b ). These results support the existence of one or more mevalonate-derived nonsterol suppressors, which are effective at the enzyme level, but not at the mRNA level. Effects of LDL and mevalonate on the compactin-induced increase in the HMG-CoA reductase activity and mRNA contents
In order to investigate whether exogenous cholesterol can substitute for the mevalonate-derived sterol suppressors, not formed in the presence of compactin, cells were incubated with medium containing 2 ,tM-compactin and different quantities of LDL. Subsequent determinations of the HMG-CoA reductase activity resulted in the data presented in Fig. 5 (a preliminary result was reported previously; Cohen et al., 1985) , and the values obtained with the HMG-CoA reductase mRNA determinations are depicted in Fig. 6 . LDL, even at high concentrations, can only partially prevent the compactin-induced increase at the level of enzyme activity (Fig. 5) , whereas exogenous mevalonate has to be present additionally for complete abolition of the compactin effect. From this experiment one cannot discriminate whether the mevalonate-derived suppressor, which could not be replaced by LDL, has a non-sterol or a sterol character. However, that is possible from the mRNA measurements (Fig. 6) , because, as shown by the data in Fig. 4 , non-sterol effectors do not play a role at the mRNA level. Fig. 6 shows that also at the mRNA level LDL, at high concentrations, could only partially prevent the increase induced by compactin and that additional mevalonate is needed to return to the same basal mRNA amounts as those obtained with LDL alone. (n = 4).
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DISCUSSION
The present study has yielded more insight into the different classes of mevalonate-derived metabolites which play a role in the feedback regulation of HGMCoA reductase in Hep G2 cells and their level of action. The results arise from comparing the amounts of reductase mRNA with the enzyme activities, measured after incubation of the cells under different conditions. To our knowledge, this is the first description of such experiments in cells of human origin.
Upon incubation of Hep G2 cells with 2 /iM-compactin the increase in mRNA compared with control values (about 2-3-fold; Figs. 1, 4 and 6) is smaller than the increase in reductase activity (5-9 times the control value; Cohen et al., 1984; Boogaard et al., 1987; cf. Fig. 5 ). This observation seems to indicate that, in Hep G2 cells, regulation by mevalonate-derived effectors takes place at the mRNA as well as at the enzyme level. This is further extended by the results discussed below, but is also in agreement with effects observed in rat liver, where mevinolin (an analogue of compactin; Alberts et al., 1980) increased (Clarke et al., 1983) and mevalonate decreased (Clarke et al., 1984 ) the reductase mRNA content, whereas mevalonate enhanced the enzyme degradation . Further, it was noted that mevinolin prevented HMG-CoA reductase enzyme degradation in Chinese-hamster ovary cells (Sinensky & Logel, 1983) . Comparable effects of compactin and mevalonate on reductase mRNA contents were measured in UT-I cells (Luskey et al., 1983) , a Chinese-hamster ovary mutant cell line, resistant to compactin , by a stable amplification of the reductase gene (Luskey et al., 1983) .
With the aid of the squalene-2,3-epoxide cyclase inhibitor, Ul 8666A (Sexton et al., 1983; Boogaard et al., 1987) , we were able to show that the mevalonate metabolites, responsible for the feedback regulation, can be divided into at least two classes with a distinguishable way of action: one class, the non-sterol suppressors, which, at total blockade of sterologenesis by 30 lLM-U18666A, are still influencing the enzyme activity (Boogaard et al., 1987) but not the mRNA contents (Fig.   4) ; the other class is the sterol repressors, which are not synthesized during the cell incubation with compactin and/or high concentrations of Ul 8666A and are effective at the mRNA level (cf. Figs. 1-4) . From experiments performed in a different way with Mev-1 cells, a Chinese-hamster ovary mutant lacking HMG-CoA synthase, it was also concluded that a nonsterol effector does not regulate at the mRNA level (Peffley & Sinenski, 1985 Boogaard et al., 1987) was larger than the decrease in mRNA (Fig. 3) . For comparison, it was reported that in UT-1 cells exogenous LDL or 25-hydroxycholesterol and in chicken myeloblasts exogenous 25-hydroxycholesterol increased the rate of enzyme degradation. Furthermore, Chin et al. (1985) showed an increase in enzyme degradation by added sterols in a Chinese-hamster mutant cell line, transfected with a HMG-CoA reductase cDNA construct, transcription of which was insensitive to exogenous sterols. Further distinction in the sterol suppressor class could be made: as shown in Fig. 5 , LDL could only partly compensate for absent mevalonate-derived suppressors when their formation was blocked by compactin. A small quantity of exogenous mevalonate, which by itself could also only in part suppress the effect of compactin, totally abolished, together with LDL, the compactin-induced increase in HMG-CoA reductase activity. From similar experiments performed with human fibroblasts (Brown & Goldstein, 1980) and with bovine endothelial cells (Cohen et al., 1982) it was concluded that exogenous LDL was compensating for all mevalonate-derived sterol effectors, whereas the exogenous mevalonate should provide the non-sterol effectors. If that would be the correct interpretation, LDL should compenstate totally for the compactin-induced increase in the mRNA contents, and additional mevalonate should not have any effect on the amount of mRNA at high LDL concentrations in the medium. As shown in Fig. 6 , that is not the case. At the mRNA level too, LDL could only partly compensate for the missing suppressors, and only together with exogenous mevalonate did it totally prevent the compactin-induced increase in the reductase mRNA.
We concluded that in Hep G2 cells non-sterol metabolites ofmevalonate regulate HMG-CoA reductase at the enzyme level, whereas mevalonate-derived sterol suppressors are additionally active at the reductase mRNA level. In the second-mentioned group we distinguish sterols which act in the same way as exogenous LDL and compounds which do not. The latter compounds may be polar sterol intermediates or side products of the cholesterol biosynthetic pathway, which cannot be formed from LDL cholesterol. For instance, the formation of a polar sterol fraction in the presence of low concentrations of U18666A (Boogaard et al., 1987) coincided with a decrease in reductase mRNA (Fig. 3) and activity (Boogaard et al., 1987 (Spencer et al., 1985; Taylor et al., 1986; Panini et al., 1986) . On the other hand, oxygenated lanosterol 14az-demethylation intermediates are also mentioned as putative repressors of the HMG-CoA reductase activity (Trzaskos et al., 1987) . The study of the effect of these oxysterols combined with LDL on HMG-CoA reductase activity and mRNA contents in Hep G2 cells may give more insight in the distinct mevalonate-derived feedback regulators.
